Clinical Trial Update: Sorafenib-RT Treatment for Liver Metastasis (SLIM) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating sorafenib combined with radiation therapy (RT) for liver metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Liver Metastasis

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Liver Metastasis, Cancer | Phase 1, Phase 2 | Status: COMPLETED